Exagen Inc.

Exagen Inc. delivers AI‑enabled, CB‑CAPs diagnostic tests under the AVISE brand that advance diagnosis, prognosis and monitoring of systemic lupus, rheumatoid arthritis and related autoimmune diseases, positioning it as a high‑growth specialty diagnostics player.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 209
HQ: Vista

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
XGN	Exagen Inc. Cap: 0.1B	EQUITY	NGM	USD	US30068X1037	Active	📈